# International Business Machines Corp: financial statements, quarterly

IBM · NYSE · CIK 51143 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ibm.md) · [Financials](/companies/ibm/financials.md) · [Filings](/companies/ibm/filings.md) · [Insiders](/companies/ibm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ibm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [17.4 d](/filings/0000051143-26-000010.md) | [14.5](/filings/0000051143-25-000032.md) | [15.8](/filings/0000051143-25-000052.md) | [15.0](/filings/0000051143-25-000064.md) | [17.6 d](/filings/0000051143-26-000010.md) | [14.5](/filings/0000051143-26-000038.md) | [17.0](/filings/0000051143-26-000078.md) | [16.3](/filings/0000051143-26-000095.md) | [19.7 d](/filings/0000051143-26-000010.md) | [15.9](/filings/0000051143-26-000038.md) | [17.2](/filings/0000051143-26-000078.md) | [17.1](/filings/0000051143-26-000095.md) |
| Cost of revenue | $bn | [7.1 d](/filings/0000051143-26-000010.md) | [6.7](/filings/0000051143-25-000032.md) | [6.8](/filings/0000051143-25-000052.md) | [6.5](/filings/0000051143-25-000064.md) | [7.1 d](/filings/0000051143-26-000010.md) | [6.5](/filings/0000051143-26-000038.md) | [7.0](/filings/0000051143-26-000078.md) | [7.0](/filings/0000051143-26-000095.md) | [7.8 d](/filings/0000051143-26-000010.md) | [7.0](/filings/0000051143-26-000038.md) | [7.3](/filings/0000051143-26-000078.md) | [7.4](/filings/0000051143-26-000095.md) |
| Gross profit | $bn | [10.3 d](/filings/0000051143-26-000010.md) | [7.7](/filings/0000051143-25-000032.md) | [9.0](/filings/0000051143-25-000052.md) | [8.4](/filings/0000051143-25-000064.md) | [10.4 d](/filings/0000051143-26-000010.md) | [8.0](/filings/0000051143-26-000038.md) | [10.0](/filings/0000051143-26-000078.md) | [9.4](/filings/0000051143-26-000095.md) | [11.9 d](/filings/0000051143-26-000010.md) | [9.0](/filings/0000051143-26-000038.md) | [9.9](/filings/0000051143-26-000078.md) | [9.7](/filings/0000051143-26-000095.md) |
| Research and development | $bn | [1.7 d](/filings/0000051143-26-000010.md) | [1.8](/filings/0000051143-25-000032.md) | [1.8](/filings/0000051143-25-000052.md) | [1.9](/filings/0000051143-25-000064.md) | [2.0 d](/filings/0000051143-26-000010.md) | [2.0](/filings/0000051143-26-000038.md) | [2.1](/filings/0000051143-26-000078.md) | [2.1](/filings/0000051143-26-000095.md) | [2.2 d](/filings/0000051143-26-000010.md) | [2.2](/filings/0000051143-26-000038.md) | [2.3](/filings/0000051143-26-000078.md) | [2.4](/filings/0000051143-26-000095.md) |
| Selling, general and administrative | $bn | [4.8 d](/filings/0000051143-26-000010.md) | [5.0](/filings/0000051143-25-000032.md) | [4.9](/filings/0000051143-25-000052.md) | [4.9](/filings/0000051143-25-000064.md) | [4.9 d](/filings/0000051143-26-000010.md) | [4.9](/filings/0000051143-26-000038.md) | [5.0](/filings/0000051143-26-000078.md) | [4.7](/filings/0000051143-26-000095.md) | [5.5 d](/filings/0000051143-26-000010.md) | [5.1](/filings/0000051143-26-000038.md) | [5.0](/filings/0000051143-26-000078.md) | [4.6](/filings/0000051143-26-000095.md) |
| Interest expense | $bn | [0.4 d](/filings/0000051143-26-000010.md) | [0.4](/filings/0000051143-25-000032.md) | [0.4](/filings/0000051143-25-000052.md) | [0.4](/filings/0000051143-25-000064.md) | [0.4 d](/filings/0000051143-26-000010.md) | [0.5](/filings/0000051143-26-000038.md) | [0.5](/filings/0000051143-26-000078.md) | [0.5](/filings/0000051143-26-000095.md) | [0.5 d](/filings/0000051143-26-000010.md) | [0.5](/filings/0000051143-26-000038.md) | [0.5](/filings/0000051143-26-000078.md) | [0.5](/filings/0000051143-26-000095.md) |
| Income tax | $bn | [0.5 d](/filings/0000051143-26-000010.md) | [(0.5)](/filings/0000051143-25-000032.md) | [0.4](/filings/0000051143-25-000052.md) | [(0.5)](/filings/0000051143-25-000064.md) | [0.4 d](/filings/0000051143-26-000010.md) | [0.1](/filings/0000051143-26-000038.md) | [0.4](/filings/0000051143-26-000078.md) | [0.7](/filings/0000051143-26-000095.md) | [(1.4) d](/filings/0000051143-26-000010.md) | [0.2](/filings/0000051143-26-000038.md) | [0.3](/filings/0000051143-26-000078.md) | [0.3](/filings/0000051143-26-000095.md) |
| Net income | $bn | [3.3 d](/filings/0000051143-26-000010.md) | [1.6](/filings/0000051143-25-000032.md) | [1.8](/filings/0000051143-25-000052.md) | [(0.3)](/filings/0000051143-25-000064.md) | [2.9 d](/filings/0000051143-26-000010.md) | [1.1](/filings/0000051143-26-000038.md) | [2.2](/filings/0000051143-26-000078.md) | [1.7](/filings/0000051143-26-000095.md) | [5.6 d](/filings/0000051143-26-000010.md) | [1.2](/filings/0000051143-26-000038.md) | [2.2](/filings/0000051143-26-000078.md) | [2.2](/filings/0000051143-26-000095.md) |
| Diluted EPS | $ per share | not reported | [1.72](/filings/0000051143-25-000032.md) | [1.96](/filings/0000051143-25-000052.md) | [(0.36)](/filings/0000051143-25-000064.md) | not reported | [1.12](/filings/0000051143-26-000038.md) | [2.31](/filings/0000051143-26-000078.md) | [1.84](/filings/0000051143-26-000095.md) | not reported | [1.28](/filings/0000051143-26-000038.md) | [2.27](/filings/0000051143-26-000078.md) | [2.30](/filings/0000051143-26-000095.md) |
| Basic EPS | $ per share | not reported | [1.75](/filings/0000051143-25-000032.md) | [1.99](/filings/0000051143-25-000052.md) | [(0.36)](/filings/0000051143-25-000064.md) | not reported | [1.14](/filings/0000051143-26-000038.md) | [2.36](/filings/0000051143-26-000078.md) | [1.87](/filings/0000051143-26-000095.md) | not reported | [1.30](/filings/0000051143-26-000038.md) | [2.30](/filings/0000051143-26-000078.md) | [2.32](/filings/0000051143-26-000095.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [13.1](/filings/0000051143-25-000015.md) | [14.6](/filings/0000051143-24-000025.md) | [12.2](/filings/0000051143-24-000039.md) | [13.2](/filings/0000051143-24-000049.md) | [13.9](/filings/0000051143-26-000010.md) | [11.0](/filings/0000051143-25-000032.md) | [11.9](/filings/0000051143-25-000052.md) | [11.6](/filings/0000051143-25-000064.md) | [13.6](/filings/0000051143-26-000095.md) | [10.8](/filings/0000051143-26-000038.md) | [7.2](/filings/0000051143-26-000078.md) | [9.2](/filings/0000051143-26-000095.md) |
| Current assets | $bn | [32.9](/filings/0000051143-25-000015.md) | [36.7](/filings/0000051143-24-000025.md) | [33.3](/filings/0000051143-24-000039.md) | [30.5](/filings/0000051143-24-000049.md) | [34.5](/filings/0000051143-26-000010.md) | [35.3](/filings/0000051143-25-000032.md) | [34.3](/filings/0000051143-25-000052.md) | [32.7](/filings/0000051143-25-000064.md) | [36.9](/filings/0000051143-26-000095.md) | [31.9](/filings/0000051143-26-000038.md) | [28.4](/filings/0000051143-26-000078.md) | [31.2](/filings/0000051143-26-000095.md) |
| Total assets | $bn | [135](/filings/0000051143-25-000015.md) | [137](/filings/0000051143-24-000025.md) | [134](/filings/0000051143-24-000039.md) | [134](/filings/0000051143-24-000049.md) | [137](/filings/0000051143-26-000010.md) | [146](/filings/0000051143-25-000032.md) | [149](/filings/0000051143-25-000052.md) | [146](/filings/0000051143-25-000064.md) | [152](/filings/0000051143-26-000095.md) | [156](/filings/0000051143-26-000038.md) | [152](/filings/0000051143-26-000078.md) | [155](/filings/0000051143-26-000095.md) |
| Current liabilities | $bn | [34.1](/filings/0000051143-25-000015.md) | [32.4](/filings/0000051143-24-000025.md) | [29.6](/filings/0000051143-24-000039.md) | [28.9](/filings/0000051143-24-000049.md) | [33.1](/filings/0000051143-26-000010.md) | [35.1](/filings/0000051143-25-000032.md) | [37.7](/filings/0000051143-25-000052.md) | [35.1](/filings/0000051143-25-000064.md) | [38.7](/filings/0000051143-26-000095.md) | [40.1](/filings/0000051143-26-000038.md) | [35.9](/filings/0000051143-26-000078.md) | [36.5](/filings/0000051143-26-000095.md) |
| Total liabilities | $bn | [113](/filings/0000051143-25-000015.md) | [114](/filings/0000051143-24-000025.md) | [110](/filings/0000051143-24-000039.md) | [110](/filings/0000051143-24-000049.md) | [110](/filings/0000051143-26-000010.md) | [119](/filings/0000051143-25-000032.md) | [121](/filings/0000051143-25-000052.md) | [118](/filings/0000051143-25-000064.md) | [119](/filings/0000051143-26-000095.md) | [123](/filings/0000051143-26-000038.md) | [118](/filings/0000051143-26-000078.md) | [119](/filings/0000051143-26-000095.md) |
| Long-term debt | $bn | [50.1](/filings/0000051143-25-000015.md) | [54.0](/filings/0000051143-24-000025.md) | [52.9](/filings/0000051143-24-000039.md) | [53.0](/filings/0000051143-24-000049.md) | [49.9](/filings/0000051143-26-000010.md) | [56.4](/filings/0000051143-25-000032.md) | [55.2](/filings/0000051143-25-000052.md) | [55.2](/filings/0000051143-25-000064.md) | [54.8](/filings/0000051143-26-000095.md) | [57.7](/filings/0000051143-26-000038.md) | [56.2](/filings/0000051143-26-000078.md) | [56.8](/filings/0000051143-26-000095.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [6.4](/filings/0000051143-25-000015.md) | [5.5](/filings/0000051143-24-000025.md) | [3.6](/filings/0000051143-24-000039.md) | [3.6](/filings/0000051143-24-000049.md) | [5.1](/filings/0000051143-26-000010.md) | [6.9](/filings/0000051143-25-000032.md) | [8.9](/filings/0000051143-25-000052.md) | [7.9](/filings/0000051143-25-000064.md) | [6.4](/filings/0000051143-26-000095.md) | [8.7](/filings/0000051143-26-000038.md) | [5.8](/filings/0000051143-26-000078.md) | [7.0](/filings/0000051143-26-000095.md) |
| Shareholders' equity | $bn | [22.5](/filings/0000051143-25-000015.md) | [23.3](/filings/0000051143-24-000025.md) | [24.0](/filings/0000051143-24-000039.md) | [24.4](/filings/0000051143-24-000049.md) | [27.3](/filings/0000051143-26-000010.md) | [26.9](/filings/0000051143-25-000032.md) | [27.5](/filings/0000051143-25-000052.md) | [27.9](/filings/0000051143-25-000064.md) | [32.6](/filings/0000051143-26-000095.md) | [33.0](/filings/0000051143-26-000038.md) | [34.5](/filings/0000051143-26-000078.md) | [35.5](/filings/0000051143-26-000095.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4,463 d](/filings/0000051143-26-000010.md) | [4,168](/filings/0000051143-25-000032.md) | [2,066 d](/filings/0000051143-25-000052.md) | [2,881 d](/filings/0000051143-25-000064.md) | [4,330 d](/filings/0000051143-26-000010.md) | [4,370](/filings/0000051143-26-000038.md) | [1,701 d](/filings/0000051143-26-000078.md) | [3,082 d](/filings/0000051143-26-000095.md) | [4,040 d](/filings/0000051143-26-000010.md) | [5,169](/filings/0000051143-26-000038.md) | [2,597 d](/filings/0000051143-26-000078.md) | [4,025 d](/filings/0000051143-26-000095.md) |
| Capital expenditure | $m | [300 d](/filings/0000051143-26-000010.md) | [239](/filings/0000051143-25-000032.md) | [220 d](/filings/0000051143-25-000052.md) | [286 d](/filings/0000051143-25-000064.md) | [303 d](/filings/0000051143-26-000010.md) | [244](/filings/0000051143-26-000038.md) | [210 d](/filings/0000051143-26-000078.md) | [255 d](/filings/0000051143-26-000095.md) | [382 d](/filings/0000051143-26-000010.md) | [232](/filings/0000051143-26-000038.md) | [229 d](/filings/0000051143-26-000078.md) | [332 d](/filings/0000051143-26-000095.md) |
| Dividends paid | $m | [1,518 d](/filings/0000051143-26-000010.md) | [1,522](/filings/0000051143-25-000032.md) | [1,536 d](/filings/0000051143-25-000052.md) | [1,543 d](/filings/0000051143-25-000064.md) | [1,546 d](/filings/0000051143-26-000010.md) | [1,549](/filings/0000051143-26-000038.md) | [1,563 d](/filings/0000051143-26-000078.md) | [1,569 d](/filings/0000051143-26-000095.md) | [1,574 d](/filings/0000051143-26-000010.md) | [1,576](/filings/0000051143-26-000038.md) | [1,590 d](/filings/0000051143-26-000078.md) | [1,596 d](/filings/0000051143-26-000095.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [918](/filings/0000051143-24-000025.md) | [919](/filings/0000051143-24-000039.md) | [924](/filings/0000051143-24-000049.md) | [933](/filings/0000051143-25-000032.md) | [934](/filings/0000051143-25-000052.md) | [924](/filings/0000051143-25-000064.md) | [945](/filings/0000051143-26-000038.md) | [948](/filings/0000051143-26-000078.md) | [949](/filings/0000051143-26-000095.md) | [952](/filings/0000051143-26-000038.md) | [953](/filings/0000051143-26-000078.md) | [954](/filings/0000051143-26-000095.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 945,120,805 at 2026-09-30, from the cover of the [10-Q filed 2026-10-22](/filings/0000051143-26-000095.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.